Crossmark

A predictive model for functional cure in chronic HBV patients treated with pegylated interferon alpha: a comparative study of multiple algorithms based on clinical data

Crossref DOI link: https://doi.org/10.1186/s12985-024-02599-1

Published Online: 2024-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ye, Ya-mei

Lin, Yong

Sun, Fang

Yang, Wen-yan

Zhou, Lina

Lin, Chun

Pan, Chen
Funding

Funding for this research was provided by:

Fujian Province Natural Science Foundation of China (2023J11475)

Fujian Province Natural Science Foundation of China (2024J011240)
License Information

Text and Data Mining valid from 2024-12-23

Version of Record valid from 2024-12-23
More Information

Article History

Received: 8 October 2024

Accepted: 4 December 2024

First Online: 23 December 2024

Declarations

:

: The study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki and Istanbul. The study was approved by the Human Ethics Committee of Mengchao Hepatobiliary Hospital (No. 2024-081-01).

: All authors read and approved the fnal manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below